Pharmabiz

DGFT extends MIP on key chemical intermediate of Cholesterol lowering drug ATS-8 imports till Nov-30

DGFT extends MIP on key chemical intermediate of Cholesterol lowering drug ATS-8 imports till Nov-30: Shardul Nautiyal, Mumbai Saturday, October 3, 2026, 08:00 Hrs [IST] The Direc ...
Pharmabiz

MDC considering G S Pharmbutor’s application for exemption of antiseptic nasal spray from price control order

MDC considering G S Pharmbutor’s application for exemption of antiseptic nasal spray from price control order: Gireesh Babu, New Delhi Saturday, October 3, 2026, 08:00 Hrs [IST] ...
Pharmabiz

CDSCO mandates inclusion of Bullous Pemphigoid as ADR in package insert of teneligliptin formulations

CDSCO mandates inclusion of Bullous Pemphigoid as ADR in package insert of teneligliptin formulations: Gireesh Babu, New Delhi Saturday, October 3, 2026, 08:00 Hrs [IST] The Centr ...
Pharmabiz

STF second sitting planned to finalize action plan against spurious drugs in Pondicherry

STF second sitting planned to finalize action plan against spurious drugs in Pondicherry: Peethaambaran Kunnathoor, Chennai Saturday, October 3, 2026, 08:00 Hrs [IST] In an ongoin ...
Pharmabiz

Regulatory affairs is evolving from compliance function to business growth engine: Dr Satish Singh

Regulatory affairs is evolving from compliance function to business growth engine: Dr Satish Singh: Yash Ved, Mumbai Saturday, October 3, 2026, 08:00 Hrs [IST] As nutraceutical an ...
Pharmabiz

Premium medical financing gaining ground in evolving healthcare landscape: Kapil Garg

Premium medical financing gaining ground in evolving healthcare landscape: Kapil Garg: Nandita Vijayasimha, Bengaluru Saturday, October 3, 2026, 08:00 Hrs [IST] Medical premium fi ...
Pharmabiz

Longevity healthcare startup Vytalyou raises Rs. 9 crore to expand clinic network

Longevity healthcare startup Vytalyou raises Rs. 9 crore to expand clinic network: Our Bureau, Mumbai Thursday, October 1, 2026, 13:30 Hrs [IST] Vytalyou, a doctor-led longevity a ...
Pharmabiz

Shilpa Biologicals launches SB HiMax platform at CPHI Milan

Shilpa Biologicals, a subsidiary of Shilpa Medicare , launches its new gene to GMP manufacturing platform, SB HiMax which ...
Pharmabiz

DBV Technologies submits BLA to US FDA for Viaskin peanut patch in children aged 4 to 7 tears

DBV Technologies submits BLA to US FDA for Viaskin peanut patch in children aged 4 to 7 tears: Châtillon, France Thursday, October 1, 2026, 18:00 Hrs [IST] DBV Technologies, a la ...
Pharmabiz

Merck’s tulisokibart meets primary and key secondary endpoints in phase 2b study in patients with moderate to severe hidradenitis suppurativa

Merck’s tulisokibart meets primary and key secondary endpoints in phase 2b study in patients with moderate to severe hidradenitis suppurativa: Rahway, New Jersey Thursday, Octob ...
Pharmabiz

Biotech firm PreferCo names Shakthi M. Nagappan as CMD

PreferCo, a precision fermentation company headquartered in Hyderabad, announced that Shakthi Nagappan will lead the company ...
Pharmabiz

Acrotech Biopharma launches Adquey in US

Acrotech Biopharma Inc., a biopharmaceutical company focused on developing and commercializing innovative proprietary medicines, announced the US launch of Adquey (difamilast 1%) ointment, a ...